Manufacture

What happened in April in the biopharma industry? Here’s our roundup of the biggest headlines and research.

How can multi-column chromatography support companies as they set their sights on intensified bioprocesses?

Is commercializing gene therapy manufacturing an unsolvable problem? We ask an expert on the frontlines.

Driven by the success of COVID-19 vaccines, mRNA products are expanding drug developers’ pipelines.

Overcoming supply chain woes will require digital intervention.

With the FDA still behind on inspections, manufacturers need to uncover their own blindspots.

How pharmaceutical therapeutics are expanding into a whole new galaxy of options.

Our eBook features mRNA vs malaria, vaccines, top tips for mRNA sequencing, and more

How can smaller biopharma companies overcome the scale up and production complexities for microbial biomanufacturing?

A microfluidic bioprocessing company has set up shop in central Scotland. We spoke to their CEO for an inside view.